Presentation TCTAP 2018

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Presenter: Duk-Woo Park

April 28, 2018

REGISTER for free or LOG IN to view this content

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Coronary

ACS/AMI

Presentation

TCTAP 2018

OPTIMA Trial

P2Y12 inhibitor

Up Next

Presentation TCTAP 2018

To Treat or Not To Treat For Gray Zone FFR (0.76~0.80)

Presenter: Seung-Jung Park

April 28, 2018

More slides +

Presentation TCTAP 2018

All Data from Real World FFR Registry

Presenter: Seung-Jung Park

April 28, 2018

Presentation

Angiography Alone vs Angiography Plus OCT to Guide PCI

July 16, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.